Protecting Life and Integrity in Research Act of 2025

Referred to the House Committee on Energy and Commerce.

Bill 119 HR 2075, also known as the "Human Fetal Tissue Research Prohibition Act," aims to prevent the Federal Government from conducting or supporting any research that involves human fetal tissue obtained from induced abortions. The bill also prohibits the solicitation or acceptance of donations of such tissue.

If passed, this legislation would have significant implications for medical research that relies on human fetal tissue for studies and advancements in various fields, such as regenerative medicine, developmental biology, and disease research. Proponents of the bill argue that using fetal tissue obtained from induced abortions is unethical and should not be supported by taxpayer dollars.

Opponents of the bill, however, argue that fetal tissue research has led to important medical breakthroughs and has the potential to further scientific understanding and potentially save lives. They argue that restricting this type of research could hinder progress in finding cures for diseases and developing new treatments. The bill has sparked debate among lawmakers and the public, with both sides presenting compelling arguments for and against its passage. It remains to be seen how this legislation will progress through Congress and what impact it may have on the future of medical research in the United States.